Virgínia Casablancas Antràs

Virgínia researches the protein and RNA interactome of TDP43, a protein central to ALS/MND pathology, following recent findings that the RNA binding of TDP43 is sensitive to its phase separation properties. 

Virgínia’s background is in Biomedical Sciences (UAB, Spain, 2014) and she later completed an MRes in Molecular Biophysics at King’s College London, funded by a LaCaixa Fellowship for Postgraduate Studies in Europe. She holds a PhD from the University of Oxford, under the supervision of Prof. Andrew Baldwin and in collaboration with Eli Lilly. In her PhD, she applied NMR and chemical kinetics approaches to the study of the mechanism of aggregation of tau, a key protein in Alzheimer's disease and other neurodegenerative diseases. Later, as a postdoc, she worked on the development of experimental and computational approaches to understand the small molecule composition of biomolecular condensates. 

Outside the lab, she enjoys playing the cello with the Oxford Millennium Orchestra.